Grundler, Rebekka <br/><br/>
FLT3-ITD and tyrosine kinase domain mutants induce 2 distinct phenotypes in a murine bone marrow transplantation model.  [electronic resource] 

 -  Blood  Jun 2005 
 - 4792-9 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0006-4971 
<br/><br/><label>Standard No.: </label>10.1182/blood-2004-11-4430  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Blotting, Southern<br/>Bone Marrow Cells--cytology<br/>Bone Marrow Transplantation<br/>Cell Separation<br/>DNA, Complementary--metabolism<br/>DNA-Binding Proteins--metabolism<br/>Flow Cytometry<br/>Green Fluorescent Proteins--metabolism<br/>Immunoblotting<br/>Immunophenotyping<br/>Immunoprecipitation<br/>Leukemia, Myeloid, Acute--genetics<br/>Mice<br/>Milk Proteins--metabolism<br/>Mutation<br/>Myeloproliferative Disorders--genetics<br/>Phenotype<br/>Point Mutation<br/>Precursor Cell Lymphoblastic Leukemia-Lymphoma--genetics<br/>Protein Structure, Tertiary<br/>Protein-Tyrosine Kinases--chemistry<br/>Proto-Oncogene Proteins--chemistry<br/>Receptor Protein-Tyrosine Kinases--chemistry<br/>Recombinant Proteins--chemistry<br/>Retroviridae--genetics<br/>STAT5 Transcription Factor<br/>Signal Transduction<br/>Splenomegaly--pathology<br/>Trans-Activators--metabolism<br/>Treatment Outcome<br/>fms-Like Tyrosine Kinase 3